IDHIFA

enasidenib · Celgene Corporation

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for IDHIFA, covering 2017-08-01 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors [Phase 2]